Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

preview_player
Показать описание
Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts.


Рекомендации по теме